GRIFOLS reported EUR4.62B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 30.94B 4.85B Nov/2026
Almirall EUR 2.28B 168.06M Nov/2026
Amadeus IT EUR 27.63B 5.27B Nov/2026
Amarin USD 290M 51M Dec/2025
argenx SE USD 60.01B 2.38B Sep/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bayer EUR 52.42B 5.31B Nov/2026
Demant DKK 83.1B 26.31B Nov/2026
Ence Energia y Celulosa EUR 540.55M 12.48M Nov/2026
Essilor EUR 76.16B 48.88B Jun/2026
Ferrovial EUR 43B 3.38B Jun/2026
Fresenius EUR 28.97B 3.77B Nov/2026
Fresenius Medical Care EUR 12.06B 1.43B Nov/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
GRIFOLS EUR 4.76B 1.02B Nov/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Inditex EUR 175.9B 18.26B Jun/2026
Lakefront Biotherapeutics EUR 2.07B 333.44M Nov/2026
Merck EUR 64.74B 46.89B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Philips EUR 24.82B 3.69B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Smith & Nephew USD 12.7B 621.83M Jun/2026
UCB EUR 46.41B 13.94B Dec/2025
Viscofan EUR 2.45B 239.2M Sep/2026